Vaxdigm history

History

REWRITING BIOLOGY

History

REWRITING BIOLOGY

2026

04

Deeptech TIPS selection, ChaperNova™–based refolding-free protein production platform advancement

Ministry of Health and Welfare project selection: ‘Development of antiviral treatment in preparation for RNA viral infectious disease (Disease X)’

2025

10

Post-TIPS project final selection: ‘Preclinical study of Pandemic Avian Influenza Vaccine’

09

SBA project selection ‘Advanced biomaterial development using AI’

2024

10

Series A Investment

05

Patent application filed for proprietary technology VXD102 ‘Microbe-based Protein ChaperNovaTM Nanoparticle production’

04

Ministry of Health and Welfare JE development governmental project selection: ‘Compulsory vaccination self-sufficiency’

01

VXD201, VXD202, VXD203 source patent license-out progressionBaculovirus-based vaccine production platform

2023

12

VXD101 and VXD103 source technology ChaperNovaTM Patent application Microbe-based protein production platform

08

Pre-A Series investment

06

Head Office and Corporate Research Institute transfer to Sungsu-dong

05

Ministry of Health and Welfare vaccine development governmental project selection: ‘Future pandemic response’

04

Ministry of Health and Welfare vaccine project selection: ‘Unresolved future response’Universal Influenza vaccine

2022

12

Assigned program: ‘WHO Global Bio Workforce Cultivation Hub’With International Vaccine Institute, Korea Health Industry Development Institute

11

Assigned project: Development planning for vaccines of new and mutant infectious diseases

10

Global vaccine collaborative research, participated in development strategy establishment research

09

Participated in vaccine industry cluster advanced plan research service

08

Selected for TIPS R&D

07

Corporate research institute approval

06

Venture enterprise approval

05

SEED Investment secured (NPI)

2021

12

Vaxdigm Co., Ltd. founded

REWRITING BIOLOGY

Vaxdigm maintains a rhythm of retainable growth, supported by our accumulating research and technological developments

REWRITING BIOLOGY

Vaxdigm maintains a rhythm of retainable growth, supported by our accumulating research and technological developments